15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Genpact Limited, 2 rate it Buy or better, 5 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $36.00 to $45.00, so the covering firms are broadly aligned. The average target of $40.43 sits 8% above the current $37.32. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.10 next quarter toward $4.51 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy229%
Hold571%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Genpact Limited.
As of Sep, 2 of 7 firms rate G a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
G EPS & revenue forecast
EPS · NEXT QUARTER
$1.10
Range $1.06 – $1.12 · 11 analysts · +13% YoY
Next period, 11 analysts expect Genpact Limited to earn $1.10 a share (range $1.06 – $1.12), versus $0.97 a year earlier. Full-year consensus is $4.12, growing to $4.51 the year after.
REVENUE · NEXT QUARTER
$1.4B
Range $1.4B – $1.4B · 11 analysts · +8% YoY
Revenue is expected to reach $1.4B (range $1.4B – $1.4B), +7.8% year-over-year. Full-year consensus is $5.4B, rising to $5.8B next year.
Top analysts covering Genpact Limited
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on G.
#1
TH
Tien-Tsin Huang
JP Morgan · Rank #58
Hold
$50.00+34.0% to target
Overall win rate
57%
+ Follow
#2
Mayank Tandon
Needham · Rank #445
Buy
$45.00+20.6% to target
Overall win rate
16%
+ Follow
#3
Bryan Bergin
TD Cowen
Buy
$43.00+15.2% to target
Coverage
—
+ Follow
#4
David Koning
Baird
Hold
$38.00+1.8% to target
Coverage
—
+ Follow
#5
James Friedman
Susquehanna
Hold
$37.00-0.9% to target
Coverage
—
+ Follow
G stock forecast FAQ
What is G's average 12-month price target?+
The 7 analysts with a live target average $40.43 for Genpact Limited over the next 12 months, ranging from a $45.00 high to a $36.00 low.
Is G stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 2 are Buy or Strong Buy, 5 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for G?+
The Street-high target is $45.00 (JP Morgan), and the Street-low is $36.00 (Citigroup). The average of all 7 active targets is $40.43.
How many Wall Street analysts cover G?+
7 analysts have an active rating on Genpact Limited, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering G?+
Among analysts who currently cover G, Tien-Tsin Huang of JP Morgan has the strongest overall Quantellect track record (Rank #58). Their current call is Hold with a $50.00 target.
What is Genpact Limited's projected EPS for next quarter?+
The consensus estimate is $1.10 per share (range $1.06 – $1.12) across 11 analysts. Full-year EPS is projected at $4.12, rising to $4.51 the following year.
How much revenue is Genpact Limited expected to report next quarter?+
Consensus revenue is $1.4B (range $1.4B – $1.4B). Full-year revenue is projected at $5.4B, growing to $5.8B next year.
Have analysts been upgrading or downgrading G lately?+
As of Sep, 2 of 7 firms rate G a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their G calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
